Literature DB >> 30296619

Characterization of a Cell-Assembled extracellular Matrix and the effect of the devitalization process.

Laure Magnan1, Gaëlle Labrunie2, Sébastien Marais3, Sylvie Rey4, Nathalie Dusserre5, Marc Bonneu6, Sabrina Lacomme7, Etienne Gontier8, Nicolas L'Heureux9.   

Abstract

We have previously shown that the Cell-Assembled extracellular Matrix (CAM) synthesized by normal, human, skin fibroblasts in vitro can be assembled in a completely biological vascular graft that was successfully tested in the clinic. The goal of this study was to perform a detailed analysis of the composition and the organization of this truly bio-material. In addition, we investigated whether the devitalization process (dehydration) used to store the CAM, and thus, make the material available "off-the-shelf," could negatively affect its organization and mechanical properties. We demonstrated that neither the thickness nor the mechanical strength of CAM sheets were significantly changed by the dehydration/freezing/rehydration cycle. The identification of over 50 extracellular matrix proteins highlighted the complex composition of the CAM. Histology showed intense collagen and glycosaminoglycan staining throughout the CAM sheet. The distribution of collagen I, collagen VI, thrombospondin-1, fibronectin-1, fibrillin-1, biglycan, decorin, lumican and versican showed various patterns that were not affected by the devitalization process. Transmission electron microscopy analysis revealed that the remarkably dense collagen network was oriented in the plane of the sheet and that neither fibril density nor diameter was changed by devitalization. Second harmonic generation microscopy revealed an intricate, multi-scale, native-like collagen fiber orientation. In conclusion, this bio-material displayed many tissue-like properties that could support normal cell-ECM interactions and allow implantation without triggering degradative responses from the host's innate immune system. This is consistent with its success in vivo. In addition, the CAM can be devitalized without affecting its mechanical or unique biological architecture. STATEMENT OF SIGNIFICANCE: The extracellular matrix (ECM) defines biological function and mechanical properties of tissues and organs. A number of promising tissue engineering approaches have used processed ECM from cadaver/animal tissues or cell-assembled ECM in vitro combined with scaffolds. We have shown the clinical potential of a scaffold-free approach based on an entirely biological material produced by human cells in culture without chemical processing. Here, we perform a comprehensive analysis of the properties of what can truly be called a bio-material. We also demonstrate that this material can be stored dried without losing its remarkable biological architecture.
Copyright © 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell-Assembled extracellular Matrix; Collagen; Entirely biological; Mass spectrometry; Scaffold-free; Tissue engineering

Mesh:

Substances:

Year:  2018        PMID: 30296619     DOI: 10.1016/j.actbio.2018.10.006

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  3 in total

1.  Cell-assembled extracellular matrix (CAM) sheet production: Translation from using human to large animal cells.

Authors:  Yoann Torres; Maude Gluais; Nicolas Da Silva; Sylvie Rey; Agathe Grémare; Laure Magnan; Fabien Kawecki; Nicolas L'Heureux
Journal:  J Tissue Eng       Date:  2021-02-12       Impact factor: 7.813

Review 2.  Designing Cardiovascular Implants Taking in View the Endothelial Basement Membrane.

Authors:  Skadi Lau; Manfred Gossen; Andreas Lendlein
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

3.  Inter-donor variability of extracellular matrix production in long-term cultures of human fibroblasts.

Authors:  Fabien Kawecki; Maude Gluais; Stéphane Claverol; Nathalie Dusserre; Todd McAllister; Nicolas L'Heureux
Journal:  Biomater Sci       Date:  2022-07-12       Impact factor: 7.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.